VDAC1 and cancer: In contrast, silencing VDAC1 expression was found to inhibit cancer cell growth and trigger metabolic rewiring in mouse xenograft models of human glioblastoma (U-87MG), lung cancer (A549), and triple negative breast cancer (MDA-MB-231) [61].